APO Research
Talk to an analyst

APO RESEARCH · REPORT

Testosterone Hormone Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Testosterone Hormone Drug Industry Growth and Trends Forecast to 2032

2 January 2026109 pages

Choose your research edition.

Industry ResearchTestosterone Hormone Drug Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Testosterone Hormone Drug Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Testosterone Hormone Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Testosterone Hormone Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Testosterone Hormone Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Testosterone Hormone Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Testosterone Hormone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Testosterone Hormone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Testosterone Hormone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Testosterone Hormone Drug include Teva, Novartis, Eli lilly, Pfizer, Bayer, AbbVie, Viatris, Upsher-Smith and Kyowa Kirin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Testosterone Hormone Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Testosterone Hormone Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Testosterone Hormone Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Testosterone Hormone Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Testosterone Hormone Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Testosterone Hormone Drug Market by Company

Teva

Novartis

Eli lilly

Pfizer

Bayer

AbbVie

Viatris

Upsher-Smith

Kyowa Kirin

Ferring Pharmaceuticals

Endo International

Actavis (Allergan)

Acerus Pharmaceuticals

Testosterone Hormone Drug Segment by Type

Gels

Patches

Injections

Testosterone Hormone Drug Segment by Application

Hospitals

Clinics

Others

Testosterone Hormone Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Testosterone Hormone Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Testosterone Hormone Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Testosterone Hormone Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Testosterone Hormone Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Testosterone Hormone Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Gels Table 2. Major Company of Patches Table 3. Major Company of Injections Table 4. Global Testosterone Hormone Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Testosterone Hormone Drug Sales by Type (2021-2026) & (K Units) Table 6. Global Testosterone Hormone Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Testosterone Hormone Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Testosterone Hormone Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Testosterone Hormone Drug Price by Type (2021-2026) & (US$/Unit) Table 10. Global Testosterone Hormone Drug Sales by Type (2027-2032) & (K Units) Table 11. Global Testosterone Hormone Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Testosterone Hormone Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Testosterone Hormone Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Testosterone Hormone Drug Price by Type (2027-2032) & (US$/Unit) Table 15. North America Testosterone Hormone Drug Sales by Type (2021-2026) & (K Units) Table 16. North America Testosterone Hormone Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Testosterone Hormone Drug Sales by Type (2021-2026) & (K Units) Table 18. Europe Testosterone Hormone Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Testosterone Hormone Drug Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Testosterone Hormone Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Testosterone Hormone Drug Sales by Type (2021-2026) & (K Units) Table 22. Latin America Testosterone Hormone Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Testosterone Hormone Drug Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Testosterone Hormone Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Testosterone Hormone Drug Industry Trends Table 26. Testosterone Hormone Drug Industry Drivers Table 27. Testosterone Hormone Drug Industry Opportunities and Challenges Table 28. Testosterone Hormone Drug Industry Restraints Table 29. Global Testosterone Hormone Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Testosterone Hormone Drug Revenue Market Share by Company (2021-2026) Table 31. Global Testosterone Hormone Drug Sales by Company (2021-2026) & (K Units) Table 32. Global Testosterone Hormone Drug Sales Share by Company (2021-2026) Table 33. Global Testosterone Hormone Drug Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Testosterone Hormone Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Testosterone Hormone Drug Major Company Production Sites and Headquarters Table 36. Global Testosterone Hormone Drug Company, Product Type & Application Table 37. Global Testosterone Hormone Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Testosterone Hormone Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Testosterone Hormone Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Testosterone Hormone Drug Sales by Region (2021-2026) & (K Units) Table 42. Global Testosterone Hormone Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Testosterone Hormone Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Testosterone Hormone Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Testosterone Hormone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Testosterone Hormone Drug Sales by Region (2027-2032) & (K Units) Table 47. Global Testosterone Hormone Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Testosterone Hormone Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Testosterone Hormone Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Testosterone Hormone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Testosterone Hormone Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Testosterone Hormone Drug Sales by Application (2021-2026) & (K Units) Table 53. Global Testosterone Hormone Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Testosterone Hormone Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Testosterone Hormone Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Testosterone Hormone Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Testosterone Hormone Drug Sales by Application (2027-2032) & (K Units) Table 58. Global Testosterone Hormone Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Testosterone Hormone Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Testosterone Hormone Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Testosterone Hormone Drug Price by Application (2027-2032) & (US$/Unit) Table 62. North America Testosterone Hormone Drug Sales by Application (2021-2026) & (K Units) Table 63. North America Testosterone Hormone Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Testosterone Hormone Drug Sales by Application (2021-2026) & (K Units) Table 65. Europe Testosterone Hormone Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Testosterone Hormone Drug Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Testosterone Hormone Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Testosterone Hormone Drug Sales by Application (2021-2026) & (K Units) Table 69. Latin America Testosterone Hormone Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Testosterone Hormone Drug Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Testosterone Hormone Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Company Information Table 73. Teva Business Overview Table 74. Teva Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Teva Testosterone Hormone Drug Product Portfolio Table 76. Teva Recent Development Table 77. Novartis Company Information Table 78. Novartis Business Overview Table 79. Novartis Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Novartis Testosterone Hormone Drug Product Portfolio Table 81. Novartis Recent Development Table 82. Eli lilly Company Information Table 83. Eli lilly Business Overview Table 84. Eli lilly Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Eli lilly Testosterone Hormone Drug Product Portfolio Table 86. Eli lilly Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Pfizer Testosterone Hormone Drug Product Portfolio Table 91. Pfizer Recent Development Table 92. Bayer Company Information Table 93. Bayer Business Overview Table 94. Bayer Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Bayer Testosterone Hormone Drug Product Portfolio Table 96. Bayer Recent Development Table 97. AbbVie Company Information Table 98. AbbVie Business Overview Table 99. AbbVie Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. AbbVie Testosterone Hormone Drug Product Portfolio Table 101. AbbVie Recent Development Table 102. Viatris Company Information Table 103. Viatris Business Overview Table 104. Viatris Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Viatris Testosterone Hormone Drug Product Portfolio Table 106. Viatris Recent Development Table 107. Upsher-Smith Company Information Table 108. Upsher-Smith Business Overview Table 109. Upsher-Smith Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Upsher-Smith Testosterone Hormone Drug Product Portfolio Table 111. Upsher-Smith Recent Development Table 112. Kyowa Kirin Company Information Table 113. Kyowa Kirin Business Overview Table 114. Kyowa Kirin Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Kyowa Kirin Testosterone Hormone Drug Product Portfolio Table 116. Kyowa Kirin Recent Development Table 117. Ferring Pharmaceuticals Company Information Table 118. Ferring Pharmaceuticals Business Overview Table 119. Ferring Pharmaceuticals Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Ferring Pharmaceuticals Testosterone Hormone Drug Product Portfolio Table 121. Ferring Pharmaceuticals Recent Development Table 122. Endo International Company Information Table 123. Endo International Business Overview Table 124. Endo International Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Endo International Testosterone Hormone Drug Product Portfolio Table 126. Endo International Recent Development Table 127. Actavis (Allergan) Company Information Table 128. Actavis (Allergan) Business Overview Table 129. Actavis (Allergan) Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Actavis (Allergan) Testosterone Hormone Drug Product Portfolio Table 131. Actavis (Allergan) Recent Development Table 132. Acerus Pharmaceuticals Company Information Table 133. Acerus Pharmaceuticals Business Overview Table 134. Acerus Pharmaceuticals Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Acerus Pharmaceuticals Testosterone Hormone Drug Product Portfolio Table 136. Acerus Pharmaceuticals Recent Development Table 137. North America Testosterone Hormone Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. North America Testosterone Hormone Drug Sales by Country (2021-2026) & (K Units) Table 139. North America Testosterone Hormone Drug Sales Market Share by Country (2021-2026) Table 140. North America Testosterone Hormone Drug Sales Forecast by Country (2027-2032) & (K Units) Table 141. North America Testosterone Hormone Drug Sales Market Share Forecast by Country (2027-2032) Table 142. North America Testosterone Hormone Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Testosterone Hormone Drug Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Testosterone Hormone Drug Market Share by Country (2021-2026) Table 145. North America Testosterone Hormone Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Testosterone Hormone Drug Market Share Forecast by Country (2027-2032) Table 147. Europe Testosterone Hormone Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Europe Testosterone Hormone Drug Sales by Country (2021-2026) & (K Units) Table 149. Europe Testosterone Hormone Drug Sales Market Share by Country (2021-2026) Table 150. Europe Testosterone Hormone Drug Sales Forecast by Country (2027-2032) & (K Units) Table 151. Europe Testosterone Hormone Drug Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Testosterone Hormone Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Testosterone Hormone Drug Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Testosterone Hormone Drug Market Share by Country (2021-2026) Table 155. Europe Testosterone Hormone Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Testosterone Hormone Drug Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Testosterone Hormone Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Testosterone Hormone Drug Sales by Country (2021-2026) & (K Units) Table 159. Asia-Pacific Testosterone Hormone Drug Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Testosterone Hormone Drug Sales Forecast by Country (2027-2032) & (K Units) Table 161. Asia-Pacific Testosterone Hormone Drug Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Testosterone Hormone Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Testosterone Hormone Drug Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Testosterone Hormone Drug Market Share by Country (2021-2026) Table 165. Asia-Pacific Testosterone Hormone Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Testosterone Hormone Drug Market Share Forecast by Country (2027-2032) Table 167. Latin America Testosterone Hormone Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Latin America Testosterone Hormone Drug Sales by Country (2021-2026) & (K Units) Table 169. Latin America Testosterone Hormone Drug Sales Market Share by Country (2021-2026) Table 170. Latin America Testosterone Hormone Drug Sales Forecast by Country (2027-2032) & (K Units) Table 171. Latin America Testosterone Hormone Drug Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Testosterone Hormone Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Testosterone Hormone Drug Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Testosterone Hormone Drug Market Share by Country (2021-2026) Table 175. Latin America Testosterone Hormone Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Testosterone Hormone Drug Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Testosterone Hormone Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Testosterone Hormone Drug Sales by Country (2021-2026) & (K Units) Table 179. Middle East and Africa Testosterone Hormone Drug Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Testosterone Hormone Drug Sales Forecast by Country (2027-2032) & (K Units) Table 181. Middle East and Africa Testosterone Hormone Drug Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Testosterone Hormone Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Testosterone Hormone Drug Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Testosterone Hormone Drug Market Share by Country (2021-2026) Table 185. Middle East and Africa Testosterone Hormone Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Testosterone Hormone Drug Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Testosterone Hormone Drug Distributors List Table 190. Testosterone Hormone Drug Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Testosterone Hormone Drug Image Figure 2. Global Testosterone Hormone Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Testosterone Hormone Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Testosterone Hormone Drug Sales (2021-2032) & (K Units) Figure 5. Gels Image Figure 6. Global Gels Sales YoY Growth (2021-2032) & (K Units) Figure 7. Patches Image Figure 8. Global Patches Sales YoY Growth (2021-2032) & (K Units) Figure 9. Injections Image Figure 10. Global Injections Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Testosterone Hormone Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Testosterone Hormone Drug Market Share by Type 2025 VS 2032 Figure 13. North America Testosterone Hormone Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Testosterone Hormone Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Testosterone Hormone Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Testosterone Hormone Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Testosterone Hormone Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Testosterone Hormone Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Testosterone Hormone Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Testosterone Hormone Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Testosterone Hormone Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Testosterone Hormone Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Testosterone Hormone Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Testosterone Hormone Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Testosterone Hormone Drug Market Share by Application 2025 VS 2032 Figure 33. North America Testosterone Hormone Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Testosterone Hormone Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Testosterone Hormone Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Testosterone Hormone Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Testosterone Hormone Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Testosterone Hormone Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Testosterone Hormone Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Testosterone Hormone Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Testosterone Hormone Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Testosterone Hormone Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Testosterone Hormone Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Testosterone Hormone Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Testosterone Hormone Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Testosterone Hormone Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Testosterone Hormone Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Testosterone Hormone Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Testosterone Hormone Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Testosterone Hormone Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Testosterone Hormone Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Testosterone Hormone Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Testosterone Hormone Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Testosterone Hormone Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Testosterone Hormone Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Testosterone Hormone Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Testosterone Hormone Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Testosterone Hormone Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Testosterone Hormone Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Testosterone Hormone Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Testosterone Hormone Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Testosterone Hormone Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Testosterone Hormone Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Testosterone Hormone Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Gels
  • Patches
  • Injections
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Teva
  • Novartis
  • Eli lilly
  • Pfizer
  • Bayer
  • AbbVie
  • Viatris
  • Upsher-Smith
  • Kyowa Kirin
  • Ferring Pharmaceuticals
  • Endo International
  • Actavis (Allergan)
  • Acerus Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Testosterone Hormone Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Testosterone Hormone Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Testosterone Hormone Drug Market by Type
  6. 1.3.1 Gels
  7. 1.3.2 Patches
  8. 1.3.3 Injections
  9. 1.4 Global Testosterone Hormone Drug Market Size by Type
  10. 1.4.1 Global Testosterone Hormone Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Testosterone Hormone Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Testosterone Hormone Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Testosterone Hormone Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Testosterone Hormone Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Testosterone Hormone Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Testosterone Hormone Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Testosterone Hormone Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Testosterone Hormone Drug Industry Trends
  2. 2.2 Testosterone Hormone Drug Industry Drivers
  3. 2.3 Testosterone Hormone Drug Industry Opportunities and Challenges
  4. 2.4 Testosterone Hormone Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Testosterone Hormone Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Testosterone Hormone Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Testosterone Hormone Drug Price (2021-2026)
  4. 3.4 Global Testosterone Hormone Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Testosterone Hormone Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Testosterone Hormone Drug Company, Product Type & Application
  7. 3.7 Global Testosterone Hormone Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Testosterone Hormone Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Testosterone Hormone Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Testosterone Hormone Drug Tier 1, Tier 2, and Tier 3
4 Testosterone Hormone Drug Regional Status and Outlook
  1. 4.1 Global Testosterone Hormone Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Testosterone Hormone Drug Historic Market Size by Region
  3. 4.2.1 Global Testosterone Hormone Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Testosterone Hormone Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Testosterone Hormone Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Testosterone Hormone Drug Forecasted Market Size by Region
  7. 4.3.1 Global Testosterone Hormone Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Testosterone Hormone Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Testosterone Hormone Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Testosterone Hormone Drug by Application
  1. 5.1 Testosterone Hormone Drug Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Testosterone Hormone Drug Market Size by Application
  6. 5.2.1 Global Testosterone Hormone Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Testosterone Hormone Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Testosterone Hormone Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Testosterone Hormone Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Testosterone Hormone Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Testosterone Hormone Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Testosterone Hormone Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Testosterone Hormone Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Testosterone Hormone Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Testosterone Hormone Drug Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Testosterone Hormone Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Testosterone Hormone Drug Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Eli lilly
  14. 6.3.1 Eli lilly Company Information
  15. 6.3.2 Eli lilly Business Overview
  16. 6.3.3 Eli lilly Testosterone Hormone Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli lilly Testosterone Hormone Drug Product Portfolio
  18. 6.3.5 Eli lilly Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Testosterone Hormone Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Testosterone Hormone Drug Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Bayer
  26. 6.5.1 Bayer Company Information
  27. 6.5.2 Bayer Business Overview
  28. 6.5.3 Bayer Testosterone Hormone Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bayer Testosterone Hormone Drug Product Portfolio
  30. 6.5.5 Bayer Recent Developments
  31. 6.6 AbbVie
  32. 6.6.1 AbbVie Company Information
  33. 6.6.2 AbbVie Business Overview
  34. 6.6.3 AbbVie Testosterone Hormone Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AbbVie Testosterone Hormone Drug Product Portfolio
  36. 6.6.5 AbbVie Recent Developments
  37. 6.7 Viatris
  38. 6.7.1 Viatris Company Information
  39. 6.7.2 Viatris Business Overview
  40. 6.7.3 Viatris Testosterone Hormone Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Viatris Testosterone Hormone Drug Product Portfolio
  42. 6.7.5 Viatris Recent Developments
  43. 6.8 Upsher-Smith
  44. 6.8.1 Upsher-Smith Company Information
  45. 6.8.2 Upsher-Smith Business Overview
  46. 6.8.3 Upsher-Smith Testosterone Hormone Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Upsher-Smith Testosterone Hormone Drug Product Portfolio
  48. 6.8.5 Upsher-Smith Recent Developments
  49. 6.9 Kyowa Kirin
  50. 6.9.1 Kyowa Kirin Company Information
  51. 6.9.2 Kyowa Kirin Business Overview
  52. 6.9.3 Kyowa Kirin Testosterone Hormone Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Kyowa Kirin Testosterone Hormone Drug Product Portfolio
  54. 6.9.5 Kyowa Kirin Recent Developments
  55. 6.10 Ferring Pharmaceuticals
  56. 6.10.1 Ferring Pharmaceuticals Company Information
  57. 6.10.2 Ferring Pharmaceuticals Business Overview
  58. 6.10.3 Ferring Pharmaceuticals Testosterone Hormone Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Ferring Pharmaceuticals Testosterone Hormone Drug Product Portfolio
  60. 6.10.5 Ferring Pharmaceuticals Recent Developments
  61. 6.11 Endo International
  62. 6.11.1 Endo International Company Information
  63. 6.11.2 Endo International Business Overview
  64. 6.11.3 Endo International Testosterone Hormone Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Endo International Testosterone Hormone Drug Product Portfolio
  66. 6.11.5 Endo International Recent Developments
  67. 6.12 Actavis (Allergan)
  68. 6.12.1 Actavis (Allergan) Company Information
  69. 6.12.2 Actavis (Allergan) Business Overview
  70. 6.12.3 Actavis (Allergan) Testosterone Hormone Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Actavis (Allergan) Testosterone Hormone Drug Product Portfolio
  72. 6.12.5 Actavis (Allergan) Recent Developments
  73. 6.13 Acerus Pharmaceuticals
  74. 6.13.1 Acerus Pharmaceuticals Company Information
  75. 6.13.2 Acerus Pharmaceuticals Business Overview
  76. 6.13.3 Acerus Pharmaceuticals Testosterone Hormone Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Acerus Pharmaceuticals Testosterone Hormone Drug Product Portfolio
  78. 6.13.5 Acerus Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Testosterone Hormone Drug Sales by Country
  2. 7.1.1 North America Testosterone Hormone Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Testosterone Hormone Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Testosterone Hormone Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Testosterone Hormone Drug Market Size by Country
  6. 7.2.1 North America Testosterone Hormone Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Testosterone Hormone Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Testosterone Hormone Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Testosterone Hormone Drug Sales by Country
  2. 8.1.1 Europe Testosterone Hormone Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Testosterone Hormone Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Testosterone Hormone Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Testosterone Hormone Drug Market Size by Country
  6. 8.2.1 Europe Testosterone Hormone Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Testosterone Hormone Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Testosterone Hormone Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Testosterone Hormone Drug Sales by Country
  2. 9.1.1 Asia-Pacific Testosterone Hormone Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Testosterone Hormone Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Testosterone Hormone Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Testosterone Hormone Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Testosterone Hormone Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Testosterone Hormone Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Testosterone Hormone Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Testosterone Hormone Drug Sales by Country
  2. 10.1.1 South America Testosterone Hormone Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Testosterone Hormone Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Testosterone Hormone Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Testosterone Hormone Drug Market Size by Country
  6. 10.2.1 South America Testosterone Hormone Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Testosterone Hormone Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Testosterone Hormone Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Testosterone Hormone Drug Sales by Country
  2. 11.1.1 Middle East and Africa Testosterone Hormone Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Testosterone Hormone Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Testosterone Hormone Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Testosterone Hormone Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Testosterone Hormone Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Testosterone Hormone Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Testosterone Hormone Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Testosterone Hormone Drug Value Chain Analysis
  2. 12.1.1 Testosterone Hormone Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Testosterone Hormone Drug Production Mode & Process
  7. 12.2 Testosterone Hormone Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Testosterone Hormone Drug Distributors
  10. 12.2.3 Testosterone Hormone Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst